(Q74284148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

E Ferriès

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Connan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Pagès

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Gaston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A M Hagnéré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Vieillefond

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Thiounn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Guillet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Choppin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

791-798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

The p53 tumour suppressor gene

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

TP53 tumor suppressor gene: a model for investigating human mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Targeting p53 as a general tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

A wild-type p53 cytotoxic T cell epitope is presented by mouse hepatocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Strategies for tumor elimination by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

p53, a potential target for tumor-directed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Altered structure of HLA class I heavy chains associated with mouse beta-2 microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

The specificity of recognition of a cytotoxic T lymphocyte epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Loss of function and p53 protein stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2801%2900266-X

7 January 2021

10.1016/S0198-8859(01)00266-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11476902%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference